Evidence map›Paper›PMID 37119507›Full record

ArticleAnnals of clinical and translational neurology2023

"Brain age" predicts disability accumulation in multiple sclerosis.

Matthew R Brier, Zhuocheng Li, Maria Ly, Helmet T Karim, Leda Liang, Weixin Du, John E McCarthy, Anne H Cross, Tammie L S Benzinger, Robert T Naismith and 1 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Article
  3. Preventing frailty in multiple sclerosis is a realistic goal - No.Multiple sclerosis (Houndmills, Basingstoke, England) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. When Age Is More Than a Number: Acceleration of Brain Aging in Neurodegenerative Diseases.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Claustrum Volume Is Reduced in Multiple Sclerosis and Predicts Disability.Annals of clinical and translational neurology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Matthew R BrierDepartment of Neurology, Washington University in St. Louis, St Louis, Missouri, USA.ORCID 0000-0001-5987-8705
Zhuocheng LiDepartment of Neurology, Washington University in St. Louis, St Louis, Missouri, USA.
Maria LyMallinckrodt Institute of Radiology, Washington University in St. Louis, St Louis, Missouri, USA.
Helmet T KarimDepartment of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Leda LiangDepartment of Mathematics and Statistics, Washington University in St. Louis, St Louis, Missouri, USA.
Weixin DuDepartment of Mathematics and Statistics, Washington University in St. Louis, St Louis, Missouri, USA.
John E McCarthyDepartment of Mathematics and Statistics, Washington University in St. Louis, St Louis, Missouri, USA.
Anne H CrossDepartment of Neurology, Washington University in St. Louis, St Louis, Missouri, USA.ORCID 0000-0003-0829-7569
Tammie L S BenzingerMallinckrodt Institute of Radiology, Washington University in St. Louis, St Louis, Missouri, USA.ORCID 0000-0002-8114-0552
Robert T NaismithDepartment of Neurology, Washington University in St. Louis, St Louis, Missouri, USA.
Salim ChahinDepartment of Neurology, Washington University in St. Louis, St Louis, Missouri, USA.
Washington University in St. Louis · USUniversity of Pittsburgh · US

Funding

Washington University Institute of Clinical and Translational Sciences (KL2) KL2TR002346 · NCATS · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 2017 to 2026
$14.0M
PET SPHINGOSINE-1-PHOSPHATE RECEPTOR 1 (S1PR1) RADIOTRACERS FOR MULTIPLE SCLEROSISR01NS103988 · NINDS · WASHINGTON UNIVERSITY · PI Tammie Lee Smith Benzinger, Zhude Tu · 2017 to 2026
$5.3M
PET Imaging of Neuroinflammation in Genetic Alzheimer's DiseaseR01AG052550 · NIA · WASHINGTON UNIVERSITY · PI Beau M Ances, Tammie Lee Smith Benzinger · 2018 to 2026
$4.2M
WASHINGTON UNIVERSITY NEUROSURGERY RESIDENT RESEARCH EDUCATION PROGRAMR25NS090978 · NINDS · WASHINGTON UNIVERSITY · PI ZIPFEL, GREGORY J · 2015 to 2023
$2.1M
Machine Learning Models for Identifying Neural Predictors of TMS Treatment Response in MDDK01MH122741 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KARIM, HELMET TALIB · 2021 to 2025
$852k
NCATS NIH HHS KL2 TR002346NIA NIH HHS R01 AG052550NIMH NIH HHS K01 MH122741NINDS NIH HHS R25 NS090978
6 · The paper itself

Abstract

objectiveNeurodegenerative conditions often manifest radiologically with the appearance of premature aging. Multiple sclerosis (MS) biomarkers related to lesion burden are well developed, but measures of neurodegeneration are less well-developed. The appearance of premature aging quantified by machine learning applied to structural MRI assesses neurodegenerative pathology. We assess the explanatory and predictive power of "brain age" analysis on disability in MS using a large, real-world dataset.

methodsBrain age analysis is predicated on the over-estimation of predicted brain age in patients with more advanced pathology. We compared the performance of three brain age algorithms in a large, longitudinal dataset (>13,000 imaging sessions from >6,000 individual MS patients). Effects of MS, MS disease course, disability, lesion burden, and DMT efficacy were assessed using linear mixed effects models.

resultsMS was associated with advanced predicted brain age cross-sectionally and accelerated brain aging longitudinally in all techniques. While MS disease course (relapsing vs. progressive) did contribute to advanced brain age, disability was the primary correlate of advanced brain age. We found that advanced brain age at study enrollment predicted more disability accumulation longitudinally. Lastly, a more youthful appearing brain (predicted brain age less than actual age) was associated with decreased disability.

interpretationBrain age is a technically tractable and clinically relevant biomarker of disease pathology that correlates with and predicts increasing disability in MS. Advanced brain age predicts future disability accumulation.

Indexed as

Aging, PrematureMultiple SclerosisAgingBiomarkersBrainDisease ProgressionHumansMagnetic Resonance ImagingBiomarkers

Identifiers

PMID37119507
PMCPMC10270248
OpenAlexW4367367685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.